Quote For Avigen Inc AVGN.OQ
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
27 Nov 2009
1.44USD
$1.44
27 Nov 2009
+0.00%
$1.44
$1.43
2,000
$1.45
$1.43
$1.64
$0.49
1.34
19,229
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Horovitz, Zola |
Chairman of the Board |
-- |
| Sauter, Andrew |
President, Chief Executive Officer,Chief Financial Officer |
522,995 |
| Johnson, Kirk |
Vice President - Research & Development, Corporate Secretary |
571,620 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$42.67 |
| Shares Outstanding (Mil.) |
29.83 |
| Float (Mil.) |
28.00 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
5.44 |
| Current Ratio |
15.73 |
| LT Debt/Equity |
0.00 |
| Total Debt/Equity |
0.00 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
5.93 |
| Price/Book(TTM) |
1.08 |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-0.63 |
| Sales(TTM) |
$0.24 |
| Book Value(MRQ) |
$1.32 |
| Cash Flow(TTM) |
$-- |
| Cash(MRQ) |
$1.21 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-39.35 |
| Return on Assets(TTM) |
-34.37 |
| Return on Investment(TTM) |
-36.27 |
| |
|
| Margins |
| Gross Margin(TTM) % |
-- |
| Operating Margin(TTM) % |
-292.47 |
| Profit Margin(TTM) % |
-262.06 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives